首页 > 最新文献

Klinicka mikrobiologie a infekcni lekarstvi最新文献

英文 中文
[The first case of scrub typhus diagnosed in a Czech traveler]. [在一名捷克旅行者身上诊断出首例恙虫病病例]。
Q3 Medicine Pub Date : 2020-09-01
Milan Trojánek, Vyacheslav Grebenyuk, Jakub Lhoťan, Naděžda Sojková, Lenka Richterová, Hana Roháčová, František Stejskal

This case report describes the first case of imported scrub typhus in a Czech traveler. The infection was diagnosed in a 38-year-old male traveler returning from a one-week business/tourist trip to Laos who presented with fever, chills, joint and muscle pain, localized inguinal lymphadenopathy, rash and a typical eschar. Although laboratory findings included elevation of CRP, hepatic aminotransferases and lactate dehydrogenase, complete blood count revealed only borderline leukocytosis with mild thrombocytopenia. The diagnosis of scrub typhus was made by serological detection of specific antibodies. The patient was treated with a 200 mg daily dose of oral doxycycline for 20 days. His clinical course was uncomplicated. The case underpins the need for a broader differential diagnosis in patients with travel-related health problems, especially those presenting with fever and rash, including less common or neglected tropical diseases.

本病例报告描述了一名捷克旅行者中首例输入性恙虫病病例。该感染是在一名从老挝进行为期一周的商务/旅游旅行返回的38岁男性旅行者中被诊断出来的,他出现发烧、寒战、关节和肌肉疼痛、局部腹沟淋巴结病、皮疹和典型的痂。尽管实验室结果包括CRP、肝转氨酶和乳酸脱氢酶升高,但全血细胞计数仅显示边缘性白细胞增多伴轻度血小板减少。通过血清学检测特异性抗体对恙虫病进行诊断。患者每日口服强力霉素200 mg,持续20天。他的临床过程并不复杂。这一病例表明,有必要对出现旅行相关健康问题的患者进行更广泛的鉴别诊断,特别是那些出现发烧和皮疹的患者,包括不太常见或被忽视的热带病患者。
{"title":"[The first case of scrub typhus diagnosed in a Czech traveler].","authors":"Milan Trojánek,&nbsp;Vyacheslav Grebenyuk,&nbsp;Jakub Lhoťan,&nbsp;Naděžda Sojková,&nbsp;Lenka Richterová,&nbsp;Hana Roháčová,&nbsp;František Stejskal","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This case report describes the first case of imported scrub typhus in a Czech traveler. The infection was diagnosed in a 38-year-old male traveler returning from a one-week business/tourist trip to Laos who presented with fever, chills, joint and muscle pain, localized inguinal lymphadenopathy, rash and a typical eschar. Although laboratory findings included elevation of CRP, hepatic aminotransferases and lactate dehydrogenase, complete blood count revealed only borderline leukocytosis with mild thrombocytopenia. The diagnosis of scrub typhus was made by serological detection of specific antibodies. The patient was treated with a 200 mg daily dose of oral doxycycline for 20 days. His clinical course was uncomplicated. The case underpins the need for a broader differential diagnosis in patients with travel-related health problems, especially those presenting with fever and rash, including less common or neglected tropical diseases.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 3","pages":"99-105"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38797495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical progression of the first wave of novel coronavirus infection in Ostrava]. 俄斯特拉发省第一波新型冠状病毒感染的临床进展
Q3 Medicine Pub Date : 2020-09-01
Lenka Petroušová, Simona da Silva, Luděk Rožnovský, Irena Martinková

Objectives: The first case of coronavirus infection in the Moravian-Silesian Region was diagnosed on March 12, 2020. The study aimed to describe the first wave and clinical manifestation of the coronavirus epidemic at the Department of Infectious Diseases in Ostrava.

Material and methods: The sample comprised a total of 195 patients requiring hospitalization at the Department of Infectious Diseases in Ostrava between March 1 and August 31, 2020. The virus was diagnosed using polymerase chain reaction from nasopharyngeal swabs in 192 patients and from the bronchoalveolar lavage in one patient. In the other two patients, serological tests were applied using virus neutralization assays and ELISA specific antibodies.

Results: The sample included 100 men and 95 women. The mean age was 69.5 years. The most common diagnosis was pneumonia, observed in 123 patients (63 %). Respiratory symptoms without pneumonia were seen in 37 patients (19 %); loss of smell and taste in 14 patients (7 %); cardiovascular complications in 9 patients (5 %); acute psychosis in 2 patients (1 %); and diarrhea and vomiting in 25 patients (13 %). The remaining 23 patients (12 %) did not present any symptoms. The mean length of hospital stay was 11 days. The most frequent comorbidity was cardiovascular disease (70 %). A total of 39 patients died (20 %); their mean age was 77 years. Mechanical ventilation was started in 16 patients, of whom 7 died (43 %). The treatment was mostly symptomatic. Hydroxychloroquine was administered to 21 patients (11 %), favipiravir to 26 patients (13 %) and remdesivir to 13 patients (6 %).

Conclusion: Respiratory complications predominated in the majority of patients with coronavirus infection. In most cases, the treatment was symptomatic. One-fifth of the patients, mostly elderly ones, died.

目的:2020年3月12日,摩拉维亚-西里西亚地区确诊首例冠状病毒感染病例。该研究旨在描述俄斯特拉发传染病科冠状病毒流行的第一波和临床表现。材料和方法:样本包括2020年3月1日至8月31日期间在俄斯特拉发传染病科住院的195名患者。利用聚合酶链反应从192例患者的鼻咽拭子和1例患者的支气管肺泡灌洗液中诊断出该病毒。在另外两例患者中,采用病毒中和试验和ELISA特异性抗体进行血清学检测。结果:样本包括100名男性和95名女性。平均年龄69.5岁。最常见的诊断是肺炎,123例患者(63%)。无肺炎的呼吸道症状37例(19%);嗅觉和味觉丧失14例(7%);心血管并发症9例(5%);急性精神病2例(1%);腹泻和呕吐25例(13%)。其余23例患者(12%)未出现任何症状。平均住院时间为11天。最常见的合并症是心血管疾病(70%)。死亡39例(20%);他们的平均年龄为77岁。16例患者开始机械通气,其中7例死亡(43%)。治疗主要是对症治疗。羟基氯喹21例(11%),法匹拉韦26例(13%),瑞德西韦13例(6%)。结论:冠状病毒感染患者以呼吸道并发症为主。在大多数情况下,治疗是对症的。五分之一的患者死亡,其中大部分是老年人。
{"title":"[Clinical progression of the first wave of novel coronavirus infection in Ostrava].","authors":"Lenka Petroušová,&nbsp;Simona da Silva,&nbsp;Luděk Rožnovský,&nbsp;Irena Martinková","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>The first case of coronavirus infection in the Moravian-Silesian Region was diagnosed on March 12, 2020. The study aimed to describe the first wave and clinical manifestation of the coronavirus epidemic at the Department of Infectious Diseases in Ostrava.</p><p><strong>Material and methods: </strong>The sample comprised a total of 195 patients requiring hospitalization at the Department of Infectious Diseases in Ostrava between March 1 and August 31, 2020. The virus was diagnosed using polymerase chain reaction from nasopharyngeal swabs in 192 patients and from the bronchoalveolar lavage in one patient. In the other two patients, serological tests were applied using virus neutralization assays and ELISA specific antibodies.</p><p><strong>Results: </strong>The sample included 100 men and 95 women. The mean age was 69.5 years. The most common diagnosis was pneumonia, observed in 123 patients (63 %). Respiratory symptoms without pneumonia were seen in 37 patients (19 %); loss of smell and taste in 14 patients (7 %); cardiovascular complications in 9 patients (5 %); acute psychosis in 2 patients (1 %); and diarrhea and vomiting in 25 patients (13 %). The remaining 23 patients (12 %) did not present any symptoms. The mean length of hospital stay was 11 days. The most frequent comorbidity was cardiovascular disease (70 %). A total of 39 patients died (20 %); their mean age was 77 years. Mechanical ventilation was started in 16 patients, of whom 7 died (43 %). The treatment was mostly symptomatic. Hydroxychloroquine was administered to 21 patients (11 %), favipiravir to 26 patients (13 %) and remdesivir to 13 patients (6 %).</p><p><strong>Conclusion: </strong>Respiratory complications predominated in the majority of patients with coronavirus infection. In most cases, the treatment was symptomatic. One-fifth of the patients, mostly elderly ones, died.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 3","pages":"80-85"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38797491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Two case reports of chronic hepatitis C retreatment]. 【慢性丙型肝炎再治疗2例报告】。
Q3 Medicine Pub Date : 2020-09-01
Luděk Rožnovský, Jakub Mrázek, Lenka Petroušová, Irena Orságová, Libuše Kabieszová, Michaela Konečná, Alena Kloudová

In a group of 211 patients with chronic hepatitis C treated with direct-acting antivirals, four experienced therapy failure. Two patients, one originally treated with dasabuvir/ombitasvir/paritaprevir/ritonavir and the other with glecaprevir/pibrentasvir, received a triple combination of sofosbuvir, velpatasvir and voxilaprevir for 12 weeks. Following the retreatment, both patients were permanently virus-free.

在接受直接抗病毒药物治疗的211例慢性丙型肝炎患者中,有4例治疗失败。两名患者,一名最初接受达沙布韦/ombitasvir/paritaprevir/利托那韦治疗,另一名接受glecaprevir/pibrentasvir治疗,接受sofosbuvir, velpatasvir和voxilaprevir的三联治疗,为期12周。再治疗后,两名患者均永久无病毒。
{"title":"[Two case reports of chronic hepatitis C retreatment].","authors":"Luděk Rožnovský,&nbsp;Jakub Mrázek,&nbsp;Lenka Petroušová,&nbsp;Irena Orságová,&nbsp;Libuše Kabieszová,&nbsp;Michaela Konečná,&nbsp;Alena Kloudová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In a group of 211 patients with chronic hepatitis C treated with direct-acting antivirals, four experienced therapy failure. Two patients, one originally treated with dasabuvir/ombitasvir/paritaprevir/ritonavir and the other with glecaprevir/pibrentasvir, received a triple combination of sofosbuvir, velpatasvir and voxilaprevir for 12 weeks. Following the retreatment, both patients were permanently virus-free.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 3","pages":"96-98"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38797493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chromoblastomycosis and phaeohyphomycosis, overlooked fungal diseases]. [嗜色菌病和褐丝菌病,被忽视的真菌疾病]。
Q3 Medicine Pub Date : 2020-06-01
Radim Dobiáš, Vladimír Havlíček

Dark-pigmented microscopic fungi are worldwide-spread soil saprophytes often found on plant remnants. In chromoblastomycosis, infectious particles of these fungi enter the human body at the site of injury and may cause chronic infection, mainly in tropical and subtropical endemic areas. Chromoblastomycosis is almost exclusively diagnosed in patients with fully functioning immunity, with typically muriform cells present in infected tissue distinguishing this condition from phaeohyphomycosis. Phaeohyphomycosis, a less specific disease caused by dark-pigmented fungi, usually makes tissue necrotize rather than proliferate, involves a broader range of pathogens of the kingdom Fungi and is mainly associated with immune disorders. Chromoblastomycosis is usually a threat to male adults, globally considered an occupational disease affecting farmers, gardeners, loggers, agricultural commodity traders and other workers exposed to contaminated soil or handling materials of plant origin. In the Czech Republic, immunocompetent patients may be at risk of chromoblastomycosis as imported infection. In the past, however, the infection was also rarely documented as autochthonous in the country.

深色微生真菌是世界范围内广泛存在的腐生植物,常在植物残体上发现。在成色菌病中,这些真菌的感染性颗粒在损伤部位进入人体,并可能引起慢性感染,主要发生在热带和亚热带流行地区。几乎只在免疫功能完全的患者中诊断出成色菌病,感染组织中通常存在多形态细胞,将其与褐丝菌病区分开来。褐丝酵母菌病是一种由深色真菌引起的特异性较低的疾病,通常使组织坏死而不是增殖,涉及真菌界更广泛的病原体,主要与免疫疾病有关。成色菌病通常对成年男性构成威胁,在全球范围内被认为是一种职业病,影响农民、园丁、伐木工人、农产品贸易商和其他接触受污染土壤或处理植物源材料的工人。在捷克共和国,免疫功能正常的患者可能有作为输入性感染的成色菌病风险。然而,在过去,这种感染也很少被记录为该国的本地感染。
{"title":"[Chromoblastomycosis and phaeohyphomycosis, overlooked fungal diseases].","authors":"Radim Dobiáš,&nbsp;Vladimír Havlíček","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Dark-pigmented microscopic fungi are worldwide-spread soil saprophytes often found on plant remnants. In chromoblastomycosis, infectious particles of these fungi enter the human body at the site of injury and may cause chronic infection, mainly in tropical and subtropical endemic areas. Chromoblastomycosis is almost exclusively diagnosed in patients with fully functioning immunity, with typically muriform cells present in infected tissue distinguishing this condition from phaeohyphomycosis. Phaeohyphomycosis, a less specific disease caused by dark-pigmented fungi, usually makes tissue necrotize rather than proliferate, involves a broader range of pathogens of the kingdom Fungi and is mainly associated with immune disorders. Chromoblastomycosis is usually a threat to male adults, globally considered an occupational disease affecting farmers, gardeners, loggers, agricultural commodity traders and other workers exposed to contaminated soil or handling materials of plant origin. In the Czech Republic, immunocompetent patients may be at risk of chromoblastomycosis as imported infection. In the past, however, the infection was also rarely documented as autochthonous in the country.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 2","pages":"54-61"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39122033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of chromoblastomycosis and phaeohyphomycosis]. [嗜色菌病和暗色菌丝病的治疗]。
Q3 Medicine Pub Date : 2020-06-01
Radim Dobiáš, Vladimír Havlíček

Cases of chromoblastomycosis are frequent in certain parts of the world, especially in some developing countries. Clinical manifestations of chromoblastomycosis are typical. To a certain extent, pathogens causing chromoblastomycosis overlap with those causing phaeohyphomycosis. Although cases of phaeohyphomycosis are not very common, they may end fatally. Therefore early management of these life-threatening infections is rather important. Targeted antifungal therapy and surgery are effective in combating these infections. Recently, several triazole antifungals such as posaconazole and isavuconazole have been available to treat even the most severe cases. Prevention of the infection should be aimed at reducing the risk of subcutaneous trauma, particularly in persons in contact with potential sources of infection such as wood materials important from endemic areas.

在世界某些地区,特别是在一些发展中国家,成色菌病病例很常见。成色菌病的临床表现是典型的。在一定程度上,引起嗜色菌病的病原体与引起褐丝酵母菌病的病原体重叠。虽然褐丝菌病的病例并不常见,但它们的结局可能是致命的。因此,对这些危及生命的感染进行早期管理是相当重要的。靶向抗真菌治疗和手术是对抗这些感染的有效方法。最近,一些三唑类抗真菌药物,如泊沙康唑和异唑康唑,已可用于治疗甚至最严重的病例。预防感染的目的应是减少皮下创伤的风险,特别是那些与潜在感染源(如来自流行地区的重要木材材料)接触的人。
{"title":"[Treatment of chromoblastomycosis and phaeohyphomycosis].","authors":"Radim Dobiáš,&nbsp;Vladimír Havlíček","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cases of chromoblastomycosis are frequent in certain parts of the world, especially in some developing countries. Clinical manifestations of chromoblastomycosis are typical. To a certain extent, pathogens causing chromoblastomycosis overlap with those causing phaeohyphomycosis. Although cases of phaeohyphomycosis are not very common, they may end fatally. Therefore early management of these life-threatening infections is rather important. Targeted antifungal therapy and surgery are effective in combating these infections. Recently, several triazole antifungals such as posaconazole and isavuconazole have been available to treat even the most severe cases. Prevention of the infection should be aimed at reducing the risk of subcutaneous trauma, particularly in persons in contact with potential sources of infection such as wood materials important from endemic areas.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 2","pages":"62-68"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39122034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Direct identification of bacteria in blood cultures by MALDI-TOF MS]. [MALDI-TOF质谱法直接鉴定血液培养细菌]。
Q3 Medicine Pub Date : 2020-06-01
Radka Homolová, Kateřina Bogdanová, Jan Bardoň, Milan Kolář

Background: Early and causal administration of antibiotics in patients with a positive blood culture is an essential prerequisite for successful treatment of infection. However, isolation and subsequent identification of bacteria in a blood culture by classical (culture) methods may last several days. MALDI-TOF MS is a method allowing rapid identification of bacteria, not only cultures from culture media, but also directly in clinical specimens.

Methods: The study included samples of positive blood cultures taken from patients in the University Hospital Olomouc between 2016 and 2018 and examined at the Department of Microbiology of the Faculty of Medicine, Palacký University Olomouc. Positive blood culture samples were processed using an in-house method involving the removal of blood cells by low-speed centrifugation. Subsequently, a pellet obtained by high-speed centrifugation and sample washing was tested by MALDI-TOF MS.

Results: A total of 110 positive blood cultures were examined using the method of direct identification. At a species level, more Gram-negative bacteria (88 %) than Gram-positive bacteria (79 %) were correctly identified, with higher identification score values being obtained for the former. Identification score values of 2.0 or higher were found in 62 % of blood cultures containing Gram-negative bacteria and 17 % of blood cultures containing Gram-positive bacteria. Identification score values ranging from 1.7 to 2.0 were found in 21 % of Gram-negative blood cultures and 33 % of blood cultures containing Gram-positive bacteria.

Conclusion: Direct identification of microorganisms from positive blood cultures using MALDI-TOF MS enables more rapid diagnosis. By reducing the time required to obtain the result of pathogen identification, it may positively affect the antibiotic treatment of patients.

背景:对血培养阳性患者早期给予抗生素治疗是成功治疗感染的必要前提。然而,通过传统的(培养)方法在血液培养中分离和随后鉴定细菌可能需要几天时间。MALDI-TOF质谱是一种快速鉴定细菌的方法,不仅可以从培养基中培养,而且可以直接在临床标本中鉴定。方法:该研究包括2016年至2018年期间从奥洛穆茨大学医院的患者身上采集的阳性血液培养样本,并在Palacký奥洛穆茨大学医学院微生物学系进行了检查。阳性血液培养样本使用内部方法处理,包括通过低速离心去除血细胞。随后,经高速离心和样品洗涤得到的球粒用MALDI-TOF ms检测。结果:采用直接鉴定法检测了110例阳性血培养。在种水平上,革兰氏阴性菌(88%)比革兰氏阳性菌(79%)得到更多的正确鉴定,革兰氏阴性菌获得更高的鉴定分值。在含有革兰氏阴性菌的62%的血培养物和含有革兰氏阳性菌的17%的血培养物中发现鉴定评分值为2.0或更高。在21%的革兰氏阴性血培养物和33%的革兰氏阳性菌血培养物中发现鉴定评分值在1.7到2.0之间。结论:利用MALDI-TOF质谱法直接鉴定阳性血培养物中的微生物,可提高诊断速度。通过减少获得病原体鉴定结果所需的时间,可能对患者的抗生素治疗产生积极影响。
{"title":"[Direct identification of bacteria in blood cultures by MALDI-TOF MS].","authors":"Radka Homolová,&nbsp;Kateřina Bogdanová,&nbsp;Jan Bardoň,&nbsp;Milan Kolář","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Early and causal administration of antibiotics in patients with a positive blood culture is an essential prerequisite for successful treatment of infection. However, isolation and subsequent identification of bacteria in a blood culture by classical (culture) methods may last several days. MALDI-TOF MS is a method allowing rapid identification of bacteria, not only cultures from culture media, but also directly in clinical specimens.</p><p><strong>Methods: </strong>The study included samples of positive blood cultures taken from patients in the University Hospital Olomouc between 2016 and 2018 and examined at the Department of Microbiology of the Faculty of Medicine, Palacký University Olomouc. Positive blood culture samples were processed using an in-house method involving the removal of blood cells by low-speed centrifugation. Subsequently, a pellet obtained by high-speed centrifugation and sample washing was tested by MALDI-TOF MS.</p><p><strong>Results: </strong>A total of 110 positive blood cultures were examined using the method of direct identification. At a species level, more Gram-negative bacteria (88 %) than Gram-positive bacteria (79 %) were correctly identified, with higher identification score values being obtained for the former. Identification score values of 2.0 or higher were found in 62 % of blood cultures containing Gram-negative bacteria and 17 % of blood cultures containing Gram-positive bacteria. Identification score values ranging from 1.7 to 2.0 were found in 21 % of Gram-negative blood cultures and 33 % of blood cultures containing Gram-positive bacteria.</p><p><strong>Conclusion: </strong>Direct identification of microorganisms from positive blood cultures using MALDI-TOF MS enables more rapid diagnosis. By reducing the time required to obtain the result of pathogen identification, it may positively affect the antibiotic treatment of patients.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 2","pages":"45-50"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39109636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chromoblastomycosis and phaeohyphomycosis - pathogenesis and laboratory diagnosis]. [嗜色菌病和褐丝酵母菌病-发病机制和实验室诊断]。
Q3 Medicine Pub Date : 2020-06-01
Radim Dobiáš, Vladimír Havlíček

Chromoblastomycosis and phaeohyphomycosis are less common fungal infections caused by dark-pigmented fungi. Virulence factors play an important role in the pathogenesis of these diseases. One of these factors, muriform cells, are the most important element for differential diagnosis of chromoblastomycosis and phaeohyphomycosis using clinical samples and various staining techniques. Accurate identification of pathogens causing chromoblastomycosis and phaeohyphomycosis is very important for correct and early antifungal therapy. Therefore, species identification of the etiological agent should be confirmed by sequencing of DNA from the culture. Early diagnosis may be crucial, especially in case of invasive forms of these infections. The diagnosis may be guided by some immunohistochemistry methods and DNA detection using polymerase chain reaction directly from clinical samples seems to be useful for identification of pathogens causing these severe and life-threatening infections.

成色菌病和暗色菌丝病是由深色真菌引起的较不常见的真菌感染。毒力因子在这些疾病的发病机制中起重要作用。其中一个因素,多形细胞,是最重要的因素,为鉴别诊断的嗜色菌病和褐丝菌病使用临床样品和各种染色技术。准确鉴定引起嗜色菌病和褐丝酵母菌病的病原菌对正确和早期的抗真菌治疗非常重要。因此,病原的种类鉴定应通过对培养物的DNA测序来确认。早期诊断可能是至关重要的,特别是在这些感染的侵袭性形式的情况下。诊断可能由一些免疫组织化学方法指导,直接从临床样本中使用聚合酶链反应进行DNA检测似乎有助于鉴定引起这些严重和危及生命的感染的病原体。
{"title":"[Chromoblastomycosis and phaeohyphomycosis - pathogenesis and laboratory diagnosis].","authors":"Radim Dobiáš,&nbsp;Vladimír Havlíček","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Chromoblastomycosis and phaeohyphomycosis are less common fungal infections caused by dark-pigmented fungi. Virulence factors play an important role in the pathogenesis of these diseases. One of these factors, muriform cells, are the most important element for differential diagnosis of chromoblastomycosis and phaeohyphomycosis using clinical samples and various staining techniques. Accurate identification of pathogens causing chromoblastomycosis and phaeohyphomycosis is very important for correct and early antifungal therapy. Therefore, species identification of the etiological agent should be confirmed by sequencing of DNA from the culture. Early diagnosis may be crucial, especially in case of invasive forms of these infections. The diagnosis may be guided by some immunohistochemistry methods and DNA detection using polymerase chain reaction directly from clinical samples seems to be useful for identification of pathogens causing these severe and life-threatening infections.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 2","pages":"69-75"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39122035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Dalbavancin and its use in the treatment of methicillin-resistant Staphylococcus aureus - induced upper limb phlegmon]. [Dalbavancin及其在耐甲氧西林金黄色葡萄球菌引起的上肢痰中的应用]。
Q3 Medicine Pub Date : 2020-06-01
Ondrej Zahornacký, Martin Novotný

The article discusses dalbavancin, a relatively new lipoglycopeptide antibiotic brought to market. It briefly describes the spectrum and mechanism of its antibacterial effect and dosing regimens that can be used in the treatment of skin and soft tissue infections. The authors present a case of a patient with shoulder phlegmon caused by MRSA who was successfully treated with this antibiotic.

本文介绍了一种新上市的脂糖肽类抗生素达巴文星。简要介绍了其抗菌作用的谱和机制以及可用于治疗皮肤和软组织感染的给药方案。作者提出了一个病例的病人与肩痰引起的MRSA谁是成功地用这种抗生素治疗。
{"title":"[Dalbavancin and its use in the treatment of methicillin-resistant Staphylococcus aureus - induced upper limb phlegmon].","authors":"Ondrej Zahornacký,&nbsp;Martin Novotný","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The article discusses dalbavancin, a relatively new lipoglycopeptide antibiotic brought to market. It briefly describes the spectrum and mechanism of its antibacterial effect and dosing regimens that can be used in the treatment of skin and soft tissue infections. The authors present a case of a patient with shoulder phlegmon caused by MRSA who was successfully treated with this antibiotic.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 2","pages":"51-53"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39122032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cost-effectiveness analysis for HIV pre-exposure prophylaxis in a high-risk population in the Czech Republic]. [在捷克共和国高危人群中进行艾滋病毒暴露前预防的成本效益分析]。
Q3 Medicine Pub Date : 2020-03-01
Jana Skoupá, Karolaacute Švecová, Svatava Snopková

Objectives: To assess the cost-effectiveness of pharmacological pre-exposure prophylaxis (PrEP) using a combination of emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) with respect to HIV transmission in high-risk patients in the Czech Republic.

Material and methods: A pharmacoeconomic model was constructed to compare costs and outcomes in a cohort with and without PrEP. Initially, a decision tree is used to evaluate short-term benefits of PrEP (proportion of HIV-infected individuals), followed by Markov cycles to simulate the course of the disease based on CD4 lymphocyte counts. The efficacy of PrEP, probability of transition between HIV infection stages, costs per category and quality of life data were derived from the literature. The results are presented as an incremental cost effectiveness ratio of incremental costs and incremental quality adjusted life-years (ICER/QALY) in a lifetime horizon with a 3% annual discount rate of costs and benefits.

Results: The FTC/TDF prophylaxis is dominant, that is, it generates lower costs and higher benefits (expressed as QALYs) in comparison with the control group without prophylaxis. A sensitivity analysis modelled all relevant parameters and all scenarios confirmed the PrEP dominance.

Conclusions: A cost-effectiveness analysis in the Czech Republic setting confirmed that pharmacological PrPE intervention is cost-effective, or cost-saving, in a high-risk population of men having sex with men, using a lifetime horizon.

目的:评估暴露前药物预防(PrEP)联合使用恩曲他滨和富马酸替诺福韦二氧吡酯(FTC/TDF)对捷克共和国高危患者HIV传播的成本效益。材料和方法:构建了一个药物经济学模型来比较有PrEP和没有PrEP的队列的成本和结果。最初,使用决策树来评估PrEP的短期效益(hiv感染者的比例),然后使用马尔可夫周期来模拟基于CD4淋巴细胞计数的疾病过程。PrEP的疗效、HIV感染阶段之间过渡的概率、每类费用和生活质量数据来源于文献。结果以递增成本和递增质量调整寿命年(ICER/QALY)在生命周期内的递增成本效益比表示,成本和效益的年贴现率为3%。结果:与未进行预防的对照组相比,FTC/TDF预防具有较低的成本和较高的效益(以QALYs表示)。敏感性分析模拟了所有相关参数,所有情景均证实PrEP占主导地位。结论:在捷克共和国进行的一项成本-效果分析证实,在男男性行为的高危人群中,以一生为标准,药物PrPE干预具有成本效益,或节省成本。
{"title":"[Cost-effectiveness analysis for HIV pre-exposure prophylaxis in a high-risk population in the Czech Republic].","authors":"Jana Skoupá,&nbsp;Karolaacute Švecová,&nbsp;Svatava Snopková","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the cost-effectiveness of pharmacological pre-exposure prophylaxis (PrEP) using a combination of emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) with respect to HIV transmission in high-risk patients in the Czech Republic.</p><p><strong>Material and methods: </strong>A pharmacoeconomic model was constructed to compare costs and outcomes in a cohort with and without PrEP. Initially, a decision tree is used to evaluate short-term benefits of PrEP (proportion of HIV-infected individuals), followed by Markov cycles to simulate the course of the disease based on CD4 lymphocyte counts. The efficacy of PrEP, probability of transition between HIV infection stages, costs per category and quality of life data were derived from the literature. The results are presented as an incremental cost effectiveness ratio of incremental costs and incremental quality adjusted life-years (ICER/QALY) in a lifetime horizon with a 3% annual discount rate of costs and benefits.</p><p><strong>Results: </strong>The FTC/TDF prophylaxis is dominant, that is, it generates lower costs and higher benefits (expressed as QALYs) in comparison with the control group without prophylaxis. A sensitivity analysis modelled all relevant parameters and all scenarios confirmed the PrEP dominance.</p><p><strong>Conclusions: </strong>A cost-effectiveness analysis in the Czech Republic setting confirmed that pharmacological PrPE intervention is cost-effective, or cost-saving, in a high-risk population of men having sex with men, using a lifetime horizon.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 1","pages":"18-24"},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38716850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Our experiences with Actinomyces urogenitalis in human clinical samples]. [我们在人类临床样本中泌尿生殖放线菌的经验]。
Q3 Medicine Pub Date : 2020-03-01
Petr Ježek, Renáta Šafránková, Lucia Mališová

Actinomyces urogenitalis is most commonly associated with the human genitourinary system, often only as the resident flora. Outside the genitourinary tract, A. urogenitalis is isolated rather sporadically. Presented are two brief case reports of human infections outside the genitourinary tract as well as experiences with microbiological identification of this actinomycete. Antibiotic susceptibility testing of actinomycetes is focused especially on their resistance to lincosamides and fluoroquinolones. The etiological relationship with the patients' clinical problems was not investigated. Previously reported cases of infections outside the genitourinary tract are also mentioned in the article. The article may aid in expanding the knowledge of the occurrence, diagnosis and susceptibility of A. urogenitalis to antibiotics, particularly in rarely reported extra-genitourinary infections caused by this species. Accurate species identification in routine laboratory practice is important both for determination of the etiological role of the microorganism and for more precise selection of empirical antibiotic therapy.

泌尿生殖道放线菌最常与人类泌尿生殖系统相关,通常仅作为常驻菌群。在泌尿生殖系统外,泌尿生殖单胞杆菌是孤立的,相当零星。本文介绍了泌尿生殖道外人类感染的两个简短病例报告,以及这种放线菌微生物学鉴定的经验。放线菌的药敏试验重点关注放线菌对林肯胺类药物和氟喹诺酮类药物的耐药性。未调查病因与患者临床问题的关系。文章中也提到了以前报道的泌尿生殖道外感染病例。本文可能有助于扩大对泌尿生殖单胞杆菌的发生、诊断和对抗生素的敏感性的认识,特别是在很少报道的由该物种引起的泌尿生殖系统外感染。在常规实验室实践中,准确的物种鉴定对于确定微生物的病原学作用和更精确地选择经验性抗生素治疗都很重要。
{"title":"[Our experiences with Actinomyces urogenitalis in human clinical samples].","authors":"Petr Ježek,&nbsp;Renáta Šafránková,&nbsp;Lucia Mališová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Actinomyces urogenitalis is most commonly associated with the human genitourinary system, often only as the resident flora. Outside the genitourinary tract, A. urogenitalis is isolated rather sporadically. Presented are two brief case reports of human infections outside the genitourinary tract as well as experiences with microbiological identification of this actinomycete. Antibiotic susceptibility testing of actinomycetes is focused especially on their resistance to lincosamides and fluoroquinolones. The etiological relationship with the patients' clinical problems was not investigated. Previously reported cases of infections outside the genitourinary tract are also mentioned in the article. The article may aid in expanding the knowledge of the occurrence, diagnosis and susceptibility of A. urogenitalis to antibiotics, particularly in rarely reported extra-genitourinary infections caused by this species. Accurate species identification in routine laboratory practice is important both for determination of the etiological role of the microorganism and for more precise selection of empirical antibiotic therapy.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 1","pages":"12-17"},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38716849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinicka mikrobiologie a infekcni lekarstvi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1